n-(3-Ethynylphenyl)cyclopropanecarboxamide, 95%, 250mg

alpha,alpha,alpha,alpha',alpha',alpha'-Hexachloro-p-xylene>98.0%(GC)25g

4-Hydroxy-3,5-dimethylbenzonitrile>95.0%(GC)1g

(2-Amino-6-bromophenyl)methanol, 95.0%, 25g

3-(Trifluoromethyl)pyrrolidin-3-ol, 98%, 1g

6-Bromo-4-iodoquinoline, 95.0%, 10g

4-methyl-5-[(3-methylphenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 90.0%, 1g

2-Azaspiro[4.5]decan-1-one, 95.0%, 100mg

Methyl 1H-benzo[d][1,2,3]triazole-7-carboxylate, 97%, 1g

Hydroxyde de sodium, min 98%, pa, ISO, en pastilles, 10 kg, emballage plastique.

2-Chloro-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 10g

3,4-Dichlorophenyl ethyl sulfide, 98.0%, 1g

2-Chloro-?,?-dimethyl-3-pyridinemethanol, 100mg